Geurts BS, Battaglia TW, van Berge Henegouwen JM, Zeverijn LJ, et al. Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours. BMC Cancer 2023;23:205.
PMID: 36870947